| Targeting TGF-β Signaling in Cancer | 2017/01/01 | English | 633 |
| Hypoxia-Inducible Factors: Master Regulators of Cancer Progression | 2016/12/01 | English | 592 |
| Turning Cold into Hot: Firing up the Tumor Microenvironment | 2020/07/01 | English | 502 |
| RNA-Binding Proteins in Cancer: Old Players and New Actors | 2017/07/01 | English | 443 |
| Glutamine Metabolism in Cancer: Understanding the Heterogeneity | 2017/03/01 | English | 422 |
| Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance | 2020/04/01 | English | 384 |
| Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside | 2018/04/01 | English | 354 |
| Endoplasmic Reticulum Stress and the Hallmarks of Cancer | 2016/05/01 | English | 338 |
| Surviving at a Distance: Organ-Specific Metastasis | 2015/09/01 | English | 324 |
| The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity | 2018/11/01 | English | 289 |
| Glioblastoma: Defining Tumor Niches | 2015/12/01 | English | 277 |
| Immunotherapy and Prevention of Pancreatic Cancer | 2018/06/01 | English | 267 |
| Mitochondria, Bioenergetics and Apoptosis in Cancer | 2017/12/01 | English | 261 |
| Metabolic Regulation of Macrophage Polarization in Cancer | 2019/12/01 | English | 254 |
| B Lymphocytes and Cancer: A Love–Hate Relationship | 2016/12/01 | English | 246 |
| Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors | 2018/05/01 | English | 246 |
| Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment | 2019/08/01 | English | 238 |
| Breast Cancer: Multiple Subtypes within a Tumor? | 2017/11/01 | English | 232 |
| Senescent Cells in Cancer Therapy: Friends or Foes? | 2020/10/01 | English | 232 |
| Radiotherapy: Changing the Game in Immunotherapy | 2016/06/01 | English | 231 |
| Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities | 2019/05/01 | English | 229 |
| KRAS Alleles: The Devil Is in the Detail | 2017/10/01 | English | 225 |
| Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges | 2017/06/01 | English | 221 |
| Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity | 2017/05/01 | English | 206 |
| 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions | 2021/03/01 | English | 200 |
| Glioblastoma Stem Cells: Driving Resilience through Chaos | 2020/03/01 | English | 197 |
| En Route to Metastasis: Circulating Tumor Cell Clusters and Epithelial-to-Mesenchymal Transition | 2015/09/01 | English | 196 |
| YAP/TAZ Signaling and Resistance to Cancer Therapy | 2019/05/01 | English | 193 |
| Migrating into the Tumor: a Roadmap for T Cells | 2017/11/01 | English | 192 |
| CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer | 2019/11/01 | English | 190 |